Lamberto impressed with earnings report stock tanks

[Anonymous]

Whats that about......Abilify flat, Onglyza doing well, Plavix dying in 3 weeks other products double digit growth...12% growth Q1.....stock bombs 2 days in a row when the street is up???

 

[L. A.]

Whats that about......Abilify flat, Onglyza doing well, Plavix dying in 3 weeks other products double digit growth...12% growth Q1.....stock bombs 2 days in a row when the street is up???

I am extremely impressed with my leadership and our results. This should give me another 26% base pay raise next year. 2-4% for you peons.

 

[Anonymous]

Whats that about......Abilify flat, Onglyza doing well, Plavix dying in 3 weeks other products double digit growth...12% growth Q1.....stock bombs 2 days in a row when the street is up???

Or to put it in perspective

Abilify flat and going. Avapro and Plavix declining and going.

Yervoy flat. Onglyza way behind expectations. Eliquis delayed. Dapa no news with FDA. Brivanib dead.